For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP) as an alternative to daily

Having HIV is associated with a greater likelihood of cigarette smoking and using smokeless tobacco, according to research conducted in 25 sub-Saharan African countries and

The number of new tuberculosis (TB) cases continued to decline in 2017, and fewer people died from the disease, according to the World Health Organization’s

A new gold-standard triple therapy for H.I.V. has just made its debut in Africa. It costs $75 a year. In the United States, many people with

Gay men in London who source their own supply of generic pre-exposure prophylaxis (PrEP) drugs, usually from overseas internet pharmacies, most often learnt about this

The High Court has today overturned Gilead’s patent extension on Truvada, the HIV drug also used in PrEP. Deborah Gold, chief executive of NAT (National

People living with HIV are twice as likely to develop cardiovascular disease (CVD), according to the findings of a meta-analysis published in Circulation. The research

With Section 377 out and implementation of the HIV and AIDS Prevention Act, patients rights groups working on AIDS prevention this new act should become

The four-symptom screen for active tuberculosis (TB) that is recommended for all people living with HIV in lower-income settings is less likely to detect active

A set of varied barriers adversely impact positive outcomes at different stages in the HIV care cascade in the rural East African context, according to